Leaflet SEVOFLURAN BAXTER 100% liquid for inhalation vapour

Product code:
W55827001
Quantity:
1
Indicated for:
general anesthesia; procedural sedation
Route of administration:
inhalation
Substance:
sevoflurane (general anesthetic)
ATC
N01AB08 — Nervous system | Anesthetics | Anesthetics, general | Halogenated hydrocarbons
Sevoflurane is an inhalation anesthetic agent used for the induction and maintenance of general anesthesia. It works by depressing the central nervous system, inducing a state of unconsciousness and muscle relaxation.

The medication is administered via inhalation under the supervision of an anesthesiologist, usually during surgical procedures. It is important for administration to be performed in controlled conditions to prevent complications.

Patients should be aware of potential side effects, such as nausea, vomiting, or hypotension. It is important to inform the doctor of any unusual symptoms after anesthesia.

Common side effects include nausea, vomiting, and hypotension. In rare cases, severe reactions such as malignant hyperthermia or liver failure may occur. Patients should be informed of these risks before administration.

General data about SEVOFLURAN BAXTER 100%

Substance:
sevoflurane
Date of latest medicines list:
01-07-2013
Product code:
W55827001
Concentration:
100%
Pharmaceutical form:
liquid for inhalation vapour
Quantity:
1
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
BAXTER SA - BELGIA
Holder:
BAXTER SA - BELGIA
Number:
6808/2014/01
Shelf life:
2 years

Pharmaceutical forms available for sevoflurane

Concentrations available for sevoflurane

  • 100%
  • 250mg